Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MetaStat Inc MTST

Healthcare Technology Biotechnology Scientific & Technical Instruments
MetaStat, Inc. is a precision medicine company. The Company's therapeutic focus targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. The Company's product development programs are focused on developing drug candidates and companion diagnostic tests that target the MENA pathway. Its pipelines include MENA Diagnostic... see more

Recent & Breaking News (GREY:MTST)

MetaStat CEO Oscar L. Bronsther, M.D. to Participate in Moffitt Cancer Center's 9th Annual Business of Biotech Conference in Tampa on April 17

Business Wire April 14, 2015

MetaStat Discussed in Medscape and Other News Outlets

Business Wire April 9, 2015

MetaStat Appoints Martin J. Driscoll to Board of Directors

Business Wire April 7, 2015

MetaStat Announces Closing of Series B Private Placement

Business Wire March 31, 2015

MetaStat Enters into Agreement to Access Tumor Samples and Clinical Data from Kaiser Foundation Hospitals

Business Wire January 27, 2015

MetaStat Closes First Round of a $3.5 Million Private Placement

Business Wire January 6, 2015

MetaStat to Present at Biotech Showcase 2015 in San Francisco

Business Wire January 6, 2015

MetaStat Completes Divestiture of Its Therapeutic Assets

Business Wire December 2, 2014

MetaStat Spotlighted in Three Publications

Business Wire October 27, 2014

MetaStat Appoints Richard J. Berman and H. Philip Goodeve to Board of Directors

Business Wire October 21, 2014

MetaStat's Diagnostic Technology Spotlighted in WABC-TV News Special on October 4

Business Wire October 8, 2014

MetaStat to Present at 13th Annual BIO Investor Forum on October 8 in San Francisco

Business Wire October 6, 2014

MetaStat to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference on September 11

Business Wire September 4, 2014

MetaStat to Present at Rodman & Renshaw 16th Annual Global Investment Conference on September 10, 2014

Business Wire August 28, 2014

MetaStat, Inc. Announces Memorandum of Understanding to Transfer its Therapeutic Business

eTeligis July 17, 2014

MetaStat, Inc. Closes Equity Financing

Accesswire July 2, 2014

Goldman Small Cap Research Issues Research Report on MetaStat, Inc.

PR Newswire June 30, 2014

MetaStat, Inc. Announces Publication of Results of its MetaSite Breast Test in the Journal of the National Cancer Institute (JNCI)

Accesswire June 4, 2014

MetaStat, Inc. Featured in Prestigious Scientific Journal - Nature

Accesswire May 16, 2014

MetaStat, Inc. Announces Issuance of New U.S. Patent for its MetaSite Breast(tm) Test

Accesswire March 6, 2014